cancer
cancer
Color Health provides the infrastructure to support durable and equitable public health across entire populations. Color’s technology and clinical services are the backbone of large-scale population health programs for over 200 institutions worldwide, with data and services spanning hereditary cancers, heart disease, infectious disease testing (including COVID-19), and community-based vaccination programs. Using a data driven approach, they’re democratizing access to health care insights.
Day One Biopharmaceuticals understands that advances in cancer research now allow drug developers to determine children and adults who may benefit from the same medicine.
Day One is a unique biopharmaceutical company on a mission to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Their distinctive approach, together with their trusted network of pediatric oncology investigators, gives them an unmatched ability to advance promising discoveries for patients of all ages. They are prepared to pursue the full potential of their therapies to improve the greatest number of lives as quickly as possible.
What Day One Biopharmaceuticals says about their mission:
"We’re ready to deliver a lasting impact for children with cancer by making sure modern targeted treatments can get to those who need them most. How? Through our deep understanding of biology and the pediatric community. We have a purposeful approach to drug development. And the right mix of people, experience and skills to drive real lasting change. We’re ready to introduce new ground-breaking treatments. Ready to be dedicated, long-term partners. Ready to solve the challenges faced by children with cancer."
Also see: Parexel International
Inspire is a vital community that supports patients, advances the understanding of the patient journey, and drives breakthroughs in pharmaceutical research.
Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world's medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Remote positions span across the globe.
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Their aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Paige is building next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.